X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (121) 121
Publication (21) 21
Patent (12) 12
Dissertation (11) 11
Newspaper Article (4) 4
Book Review (3) 3
Conference Proceeding (3) 3
Book / eBook (2) 2
Book Chapter (2) 2
Compact Disc (2) 2
Magazine Article (2) 2
Trade Publication Article (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (48) 48
humans (36) 36
male (33) 33
female (31) 31
animals (22) 22
middle aged (19) 19
aged (18) 18
atrial fibrillation (15) 15
stroke (15) 15
risk factors (13) 13
cardiac & cardiovascular systems (12) 12
prospective studies (12) 12
coffee mills (11) 11
domestic articles or appliances (11) 11
domestic washing or cleaning (11) 11
furniture (11) 11
human necessities (11) 11
spice mills (11) 11
stroke - prevention & control (11) 11
suction cleaners in general (11) 11
abridged index medicus (10) 10
neurology (10) 10
aged, 80 and over (9) 9
analysis (9) 9
management (9) 9
pharmacology & pharmacy (9) 9
rats (9) 9
risk (9) 9
double-blind method (8) 8
registries (8) 8
adult (7) 7
atrial fibrillation - drug therapy (7) 7
medicine, general & internal (7) 7
research (7) 7
therapy (7) 7
warfarin (7) 7
cardiovascular disease (6) 6
care and treatment (6) 6
cell biology (6) 6
comparative analysis (6) 6
guidelines (6) 6
mortality (6) 6
phenotype (6) 6
time factors (6) 6
treatment outcome (6) 6
administration, oral (5) 5
alzheimer's disease (5) 5
anticoagulants (5) 5
anticoagulants - therapeutic use (5) 5
biochemical research methods (5) 5
diagnosis (5) 5
drug therapy (5) 5
expression (5) 5
hemorrhage (5) 5
life sciences (5) 5
medical research (5) 5
mice (5) 5
multidisciplinary sciences (5) 5
neuropathic pain (5) 5
neurosciences (5) 5
patients (5) 5
physiology (5) 5
prevention (5) 5
proteins (5) 5
rats, sprague-dawley (5) 5
reproducibility of results (5) 5
research article (5) 5
stroke prevention (5) 5
anticoagulants - adverse effects (4) 4
anticoagulation (4) 4
architecture (4) 4
arrhythmia (4) 4
article (4) 4
atrial fibrillation - complications (4) 4
atrial fibrillation - mortality (4) 4
cancer (4) 4
cardiology (4) 4
cardiovascular diseases (4) 4
cardiovascular diseases - prevention & control (4) 4
cells, cultured (4) 4
chemistry, analytical (4) 4
clinical neurology (4) 4
clinical trials (4) 4
diagnostic imaging (4) 4
health risks (4) 4
liquid chromatography (4) 4
medicine (4) 4
oncology (4) 4
pharmacokinetics (4) 4
physiological aspects (4) 4
prevalence (4) 4
risk assessment (4) 4
rna (4) 4
sensory neurons (4) 4
stroke - epidemiology (4) 4
stroke - etiology (4) 4
studies (4) 4
usage (4) 4
vitamin k - antagonists & inhibitors (4) 4
women (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Scientific Reports, ISSN 2045-2322, 01/2016, Volume 6, Issue 1, p. 19906
Iridescent color appearances are widespread in nature. They arise from the interaction of light with micron- and submicron-sized physical structures spatially... 
PSEUDOMONAS-AERUGINOSA | MULTIDISCIPLINARY SCIENCES | ARCHITECTURE | RHODOPHYTA | FISH | DIVERSITY | STRUCTURAL COLORS | Biofilms | Iridescence | Light | Color | Flavobacteriaceae - ultrastructure | Flavobacteriaceae - physiology | Colonies | Crystals | Periodicity | Marine organisms | Gliding
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2015, Volume 373, Issue 10, pp. 895 - 907
Journal Article
by Hernandez, Adrian F and Green, Jennifer B and Janmohamed, Salim and D'Agostino, Ralph B and Granger, Christopher B and Jones, Nigel P and Leiter, Lawrence A and Rosenberg, Anne E and Sigmon, Kristina N and Somerville, Matthew C and Thorpe, Karl M and McMurray, John J V and Del Prato, Stefano and Del Prato, Stefano and McMurray, John J.V and D'Agostino, Ralph B and Granger, Christopher B and Hernandez, Adrian F and Janmohamed, Salim and Leiter, Lawrence A and Califf, Robert M and Holman, Rury and DeMets, David and Riddle, Matthew and Goodman, Shaun and McGuire, Darren and Alexander, Karen and Devore, Adam and Melloni, Chiara and Patel, Chetan and Kong, David and Bloomfield, Gerald and Roe, Matthew and Tricoci, Pierluigi and Harrison, Rob and Lopes, Renato and Mathews, Robin and Mehta, Rajendra and Schuyler Jones, William and Vemulapalli, Sreekanth and Povsic, Thomas and Eapen, Zubin and Dombrowski, Keith and Kolls, Brad and Jordan, Dedrick and Ambrosy, Andrew and Greene, Stephen and Mandawat, Aditya and Shavadia, Jay and Cooper, Lauren and Sharma, Abhinav and Guimaraes, Patricia and Friedman, Daniel and Wilson, Matt and Endsley, Patricia and Gentry, Tracy and Collier, Jeannie and Perez, Kathleen and James, Kourtnei and Roush, Jennifer and Pope, Connie and Howell, Christina and Johnson, Megan and Bailey, Matt and Cole, Joanna and Akers, Teresa and Vandyne, Beth and Thomas, Betsy and Rich, Jenny and Bartone, Susan and Beaulieu, Gail and Brown, Kim and Chau, Tuan and Christian, Tamra and Coker, Rebecca and Greene, Deb and Haddock, Trevorlyn and Jenkins, Wendy and Haque, Ghazala and Marquess, Marsha and Pesarchick, Jean and Rethaford, Renee and Stone, Allegra and Al Kawas, Firas and Anderson, Michelle and Enns, Robert and Sinay, Isaac and Mathieu, Chantal and Yordanov, Victor and Hramiak, Irene and Haluzik, Martin and Galatius, Søren and Guerci, Bruno and Nauck, Michael and Migdalis, Ilias and Tan, Choon Beng Kathryn and Kocsis, Gyozo and Giaccari, Andrea and Lee, Moon Kyu and Muñoz, Ernesto German Cardona and ... and Harmony Outcomes committees and investigators and Harmony Outcomes Comm Investigator
The Lancet, ISSN 0140-6736, 10/2018, Volume 392, Issue 10157, pp. 1519 - 1529
Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular... 
MEDICINE, GENERAL & INTERNAL | RISK | METAANALYSIS | MELLITUS | SAFETY | RECEPTOR AGONISTS | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Glucagon-Like Peptide 1 - administration & dosage | Glucagon-Like Peptide 1 - analogs & derivatives | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Stroke - etiology | Hypoglycemic Agents - administration & dosage | Injections, Subcutaneous | Adult | Female | Aged | Myocardial Infarction - prevention & control | Diabetes Mellitus, Type 2 - drug therapy | Myocardial Infarction - etiology | Diabetes Mellitus, Type 2 - complications | Glucagon-Like Peptide 1 - therapeutic use | Myocardial infarction | Diabetic retinopathy | Heart attacks | Peptides | Glucagon | Medical services | Clinical trials | Cardiovascular disease | Thyroid gland | Incidence | Thyroid carcinoma | Randomization | Motivation | Hemoglobin | Diuretics | Diabetes mellitus (non-insulin dependent) | Glucagon-like peptide 1 | Thyroid | Cerebral infarction | Stroke | Diabetes mellitus | Pancreatitis | Health risks | Risk reduction | Disease control | Patients | Organic chemistry | Interactive systems | Pancreatic cancer | Fatalities | Infarction | Diabetes | Cardiovascular diseases | Health risk assessment
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 12, pp. 1119 - 1131
Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The... 
no | C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Klinisk medicin | Clinical Medicine
Journal Article